Effect of Extraneal (Icodextrin) on Triglyceride Levels in PD Patients

Trial Profile

Effect of Extraneal (Icodextrin) on Triglyceride Levels in PD Patients

Phase of Trial: Phase II

Latest Information Update: 09 Aug 2016

At a glance

  • Drugs Icodextrin (Primary) ; Glucose
  • Indications Hypertriglyceridaemia
  • Focus Therapeutic Use
  • Acronyms EXIT-study
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 05 Aug 2016 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
    • 17 Aug 2015 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top